The selection of Robert F. Kennedy Jr. to lead the Department of Health and Human Services (HHS) sent shock waves through the pharmaceutical industry. But many of the industry sources and outside lobbyists who spoke to The Hill said they are not prepared to outright oppose Kennedy, at least for now. Lobbyists said they…